1. Home
  2. NEPH vs ICCM Comparison

NEPH vs ICCM Comparison

Compare NEPH & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • ICCM
  • Stock Information
  • Founded
  • NEPH 1997
  • ICCM 2006
  • Country
  • NEPH United States
  • ICCM Israel
  • Employees
  • NEPH N/A
  • ICCM N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • ICCM
  • Sector
  • NEPH Health Care
  • ICCM
  • Exchange
  • NEPH Nasdaq
  • ICCM Nasdaq
  • Market Cap
  • NEPH 60.4M
  • ICCM 49.1M
  • IPO Year
  • NEPH 2004
  • ICCM N/A
  • Fundamental
  • Price
  • NEPH $4.37
  • ICCM $0.71
  • Analyst Decision
  • NEPH Strong Buy
  • ICCM Strong Buy
  • Analyst Count
  • NEPH 2
  • ICCM 1
  • Target Price
  • NEPH $5.50
  • ICCM $2.50
  • AVG Volume (30 Days)
  • NEPH 70.3K
  • ICCM 463.0K
  • Earning Date
  • NEPH 11-06-2025
  • ICCM 11-19-2025
  • Dividend Yield
  • NEPH N/A
  • ICCM N/A
  • EPS Growth
  • NEPH N/A
  • ICCM N/A
  • EPS
  • NEPH 0.14
  • ICCM N/A
  • Revenue
  • NEPH $17,930,000.00
  • ICCM $2,787,000.00
  • Revenue This Year
  • NEPH $24.38
  • ICCM $2.92
  • Revenue Next Year
  • NEPH $10.16
  • ICCM $57.81
  • P/E Ratio
  • NEPH $31.69
  • ICCM N/A
  • Revenue Growth
  • NEPH 32.36
  • ICCM N/A
  • 52 Week Low
  • NEPH $1.39
  • ICCM $0.56
  • 52 Week High
  • NEPH $5.98
  • ICCM $1.66
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 42.66
  • ICCM 36.88
  • Support Level
  • NEPH $3.66
  • ICCM $0.66
  • Resistance Level
  • NEPH $4.72
  • ICCM $0.72
  • Average True Range (ATR)
  • NEPH 0.55
  • ICCM 0.04
  • MACD
  • NEPH -0.14
  • ICCM 0.01
  • Stochastic Oscillator
  • NEPH 35.93
  • ICCM 41.49

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: